Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy
As professional antigen presenting cells (APCs) capable of eliciting primary immune responses among naïve T cells, dendritic cells (DCs) offer an attractive target for immune intervention. While some strategies for vaccination have sought to deliver antigens direct to DCs in vivo, others have pulsed...
Үндсэн зохиолчид: | Bravo, M, Davies, TJ, Fairchild, PJ |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Bioinsights Publishing Ltd
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Integrating next-generation dendritic Cell vaccines into the current cancer immunotherapy landscape.
-н: Garg, A, зэрэг
Хэвлэсэн: (2017) -
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
-н: Horton, C, зэрэг
Хэвлэсэн: (2019) -
Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
-н: Sachamitr, P, зэрэг
Хэвлэсэн: (2012) -
Next‐generation Gene Silencers for Cancer Immunotherapy
-н: Ng, Aik Seng
Хэвлэсэн: (2017) -
Financial viability and technical evaluation of dendritic cell-carrying "vaccination nodes" for immunotherapy
-н: Song, Andrew, M. Eng. Massachusetts Institute of Technology
Хэвлэсэн: (2009)